Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON26931Active, not recruiting
Randomised, double-blind trial of prednisolone in rhinosinusitis, sponsored by Julius Center for Health Sciences and Primary Care. Primary endpoint: Resolution of facial pain at day 7. Started Sep 2008; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON26931.